:

XCURES RAISES $46M SERIES B FOR AI HEALTH DATA

AI DESK1 MIN READ
THU, JUN 25, 2026

■ AI-SUMMARIZED FROM 1 SOURCE ▸ TIMELINE

XCures, an AI platform for streamlining patient data and medical records, closed a $46 million Series B round at a $127 million post-money valuation. The funding brings the company's total capital raised to $76 million.

XCures uses artificial intelligence to organize and process patient data across healthcare systems. The Series B round values the startup at $127 million, nearly double its previous valuation. The company operates in a growing segment of healthtech focused on data interoperability and administrative efficiency. Healthcare systems and providers face significant challenges managing fragmented patient records across multiple platforms and institutions. XCures joins a wave of AI-focused healthcare startups attracting substantial funding as the industry seeks to reduce operational costs and improve data accessibility. The startup has now secured $76 million across its funding rounds. The Series B financing will support product development and expansion of the company's platform capabilities.

■ SOURCES

Techmeme

■ SUMMARY WRITTEN BY AI FROM THE LINKS ABOVE

■ MORE FROM THE STARTUPS DESK

224 Ventures, a new AI-native investment firm founded by former AIX Ventures co-founder Shaun Johnson, ex-Google DeepMind researcher Oriol Vinyals, and AI pioneer Yann LeCun, plans to make seed-stage bets with over $100 million in assets under management.

YESTERDAYAI Desk

Marco Arment has released Unforgetful, a reminders app designed to prevent users from dismissing notifications too easily. The app aims to solve the problem of ignored reminders through friction-based design.

YESTERDAYIndustry Desk

Fermi Inc. has appointed Lee McIntire as chief executive officer, approximately four months following the departure of its co-founder from the position.

AUG 14Industry Desk

An Indian startup is combining trained dogs with artificial intelligence to detect cancer at early stages. The approach leverages canines' natural ability to identify disease markers through scent.

AUG 14AI Desk

■ SUBSCRIBE TO THE DAILY BRIEF

ONE EMAIL, 5 STORIES, 06:00 UTC. UNSUBSCRIBE ANYTIME.